{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:42:59Z","timestamp":1790700179025,"version":"4.1.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Productiva","doi-asserted-by":"publisher","award":["PICT 2015-2654"],"award-info":[{"award-number":["PICT 2015-2654"]}],"id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Productiva","doi-asserted-by":"publisher","award":["PIP 5205\/15"],"award-info":[{"award-number":["PIP 5205\/15"]}],"id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Productiva","doi-asserted-by":"publisher","award":["PIP DD94"],"award-info":[{"award-number":["PIP DD94"]}],"id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.abb.2021.108788","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T22:44:16Z","timestamp":1612392256000},"page":"108788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cholesterol in myasthenia gravis"],"prefix":"10.1016","volume":"701","author":[{"given":"Mariela L.","family":"Paz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-681X","authenticated-orcid":false,"given":"Francisco J.","family":"Barrantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.abb.2021.108788_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.abb.2021.108788_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2020.03.009","article-title":"Antibodies and receptors: from neuromuscular junction to central nervous system","volume":"439","author":"Vincent","year":"2020","journal-title":"Neuroscience"},{"issue":"4\u20135","key":"10.1016\/j.abb.2021.108788_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1113\/jphysiol.1907.sp001236","article-title":"On the contraction of muscle, chiefly in relation to the presence of \"receptive\" substances: Part I","volume":"36","author":"Langley","year":"1907","journal-title":"J.\u00a0Physiol."},{"issue":"4","key":"10.1016\/j.abb.2021.108788_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1113\/jphysiol.1936.sp003371","article-title":"Release of acetylcholine at voluntary motor nerve endings","volume":"86","author":"Dale","year":"1936","journal-title":"J.\u00a0Physiol."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1113\/jphysiol.1955.sp005297","article-title":"On the localization of acetylcholine receptors","volume":"128","author":"Del Castillo","year":"1955","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.abb.2021.108788_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/biom10040547","article-title":"Discovery of the first neurotransmitter receptor: the acetylcholine nicotinic receptor","volume":"10","author":"Changeux","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.abb.2021.108788_bib7","doi-asserted-by":"crossref","first-page":"596981","DOI":"10.3389\/fneur.2020.596981","article-title":"Myasthenia gravis: autoantibody specificities and their role in MG management","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.abb.2021.108788_bib8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0006-291X(77)91203-7","article-title":"Phospholipase A inhibition of acetylcholine receptor function in Torpedo californica membrane vesicles","volume":"79","author":"Andreasen","year":"1977","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.abb.2021.108788_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1432-1033.1978.tb12184.x","article-title":"Recovery of some functional properties of the detergent- extracted cholinergic receptor protein from Torpedo marmorata after reintegration into a membrane environment","volume":"84","author":"Briley","year":"1978","journal-title":"Eur. J. Biochem."},{"issue":"15","key":"10.1016\/j.abb.2021.108788_bib10","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1021\/bi00258a015","article-title":"Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles","volume":"21","author":"Criado","year":"1982","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.abb.2021.108788_bib11","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1021\/bi00266a004","article-title":"Translational diffusion of acetylcholine receptor (monomeric and dimeric forms) of Torpedo marmorata reconstituted into phospholipid bilayers studied by fluorescence recovery after photobleaching","volume":"21","author":"Criado","year":"1982","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0005-2736(83)90379-6","article-title":"Reconstitution of acetylcholine receptor function in lipid vesicles of defined composition","volume":"727","author":"Ochoa","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.abb.2021.108788_bib13","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1073\/pnas.75.9.4329","article-title":"Immobilized lipid in acetylcholine receptor-rich membranes from Torpedo marmorata","volume":"75","author":"Marsh","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0005-2736(81)90516-2","article-title":"Phospholipid chain immobilization and steroid rotational immobilization in acetylcholine receptor-rich membranes from Torpedo marmorata","volume":"645","author":"Marsh","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.abb.2021.108788_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48\u201349","author":"Berrih-Aknin","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib16","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1021\/acschemneuro.9b00041","article-title":"Autoimmune attack of the neuromuscular junction in myasthenia gravis: nicotinic acetylcholine receptors and other targets","volume":"10","author":"Paz","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061677","article-title":"The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes","volume":"19","author":"Rodr\u00edguez Cruz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1172\/JCI117369","article-title":"Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor","volume":"94","author":"Vernet-der Garabedian","year":"1994","journal-title":"J.\u00a0Clin. Invest."},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/506257","article-title":"Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit","volume":"79","author":"Hoffmann","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0896-8411(91)90017-7","article-title":"Anti-acetylcholine receptor antibodies in neonatal myasthenia gravis: heterogeneity and pathogenic significance","volume":"4","author":"Eymard","year":"1991","journal-title":"J.\u00a0Autoimmun."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/WNL.48.1.50","article-title":"The fetal\/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn","volume":"48","author":"Gardnerova","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.abb.2021.108788_bib22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1212\/WNL.43.5.983","article-title":"The \u2018embryonic\u2019 gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle","volume":"43","author":"Horton","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-5728(84)90020-1","article-title":"Neonatal myasthenia gravis. Anti-acetylcholine receptor antibodies in the amniotic fluid","volume":"6","author":"Morel","year":"1984","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"10","key":"10.1016\/j.abb.2021.108788_bib24","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1172\/JCI119048","article-title":"Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function","volume":"98","author":"Riemersma","year":"1996","journal-title":"J.\u00a0Clin. Invest."},{"issue":"7","key":"10.1016\/j.abb.2021.108788_bib25","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1083\/jcb.200401115","article-title":"Nerve-independent formation of a topologically complex postsynaptic apparatus","volume":"164","author":"Kummer","year":"2004","journal-title":"J.\u00a0Cell Biol."},{"issue":"31","key":"10.1016\/j.abb.2021.108788_bib26","doi-asserted-by":"crossref","first-page":"11088","DOI":"10.1073\/pnas.0504806102","article-title":"Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter","volume":"102","author":"Misgeld","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.abb.2021.108788_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.20440","article-title":"Molecular architecture of the neuromuscular junction","volume":"33","author":"Hughes","year":"2006","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.abb.2021.108788_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1101\/gad.180885.111","article-title":"Structural basis of agrin-LRP4-MuSK signaling","volume":"26","author":"Zong","year":"2012","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for Agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/dneu.22070","article-title":"Regulation of muscle acetylcholine receptor turnover by \u03b2 subunit tyrosine phosphorylation","volume":"73","author":"Rudell","year":"2013","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.abb.2021.108788_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.iy.03.040185.000545","article-title":"Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and lambert-eaton syndrome","volume":"3","author":"Lindstrom","year":"1985","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.abb.2021.108788_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1042\/bst0190180","article-title":"Autoimmunity to acetylcholine receptors in myasthenia gravis","volume":"19","author":"Vincent","year":"1991","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ncl.2018.01.004","article-title":"Muscle-specific tyrosine kinase and myasthenia gravis owing to other antibodies","volume":"36","author":"Rivner","year":"2018","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.abb.2021.108788_bib34","series-title":"Autoantibodies to Low-Density Lipoprotein Receptor\u2013related Protein 4 in Myasthenia gravis","first-page":"418","volume":"69","author":"Higuchi","year":"2011"},{"key":"10.1016\/j.abb.2021.108788_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuroscience.2018.01.015","article-title":"Induction of anti-agrin antibodies causes myasthenia gravis in mice","volume":"373","author":"Yan","year":"2018","journal-title":"Neuroscience"},{"issue":"Pt 7","key":"10.1016\/j.abb.2021.108788_bib36","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ncl.2018.01.001","article-title":"Nature and action of antibodies in myasthenia gravis","volume":"36","author":"Ruff","year":"2018","journal-title":"Neurol. Clin."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/1744666X.4.1.43","article-title":"Effect of complement and its regulation on myasthenia gravis pathogenesis","volume":"4","author":"Kusner","year":"2008","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib39","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1073\/pnas.74.5.2130","article-title":"Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins","volume":"74","author":"Appel","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.abb.2021.108788_bib40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1083\/jcb.200709086","article-title":"Nicotinic acetylcholine receptor is internalized via a Rac-dependent, dynamin-independent endocytic pathway","volume":"181","author":"Kumari","year":"2008","journal-title":"J.\u00a0Cell Biol."},{"issue":"7","key":"10.1016\/j.abb.2021.108788_bib41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/jnnp.43.7.601","article-title":"Mechanisms of acetylcholine receptor loss in myasthenia gravis","volume":"43","author":"Drachman","year":"1980","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"issue":"26","key":"10.1016\/j.abb.2021.108788_bib43","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.abb.2021.108788_bib44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.abb.2021.108788_bib45","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.nmd.2017.04.002","article-title":"HLA and age of onset in myasthenia gravis","volume":"27","author":"Santos","year":"2017","journal-title":"Neuromuscul. Disord.: NMD"},{"issue":"9","key":"10.1016\/j.abb.2021.108788_bib46","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bbamem.2015.03.028","article-title":"Phylogenetic conservation of protein\u2013lipid motifs in pentameric ligand-gated ion channels","volume":"1848","author":"Barrantes","year":"2015","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.abb.2021.108788_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2016.03.003","article-title":"From hopanoids to cholesterol: molecular clocks of pentameric ligand-gated ion channels","volume":"63","author":"Barrantes","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib48","first-page":"620","article-title":"Modulation of nicotinic acetylcholine receptor function through the outer and middle rings of transmembrane domains","volume":"6","author":"Barrantes","year":"2003","journal-title":"Curr. Opin. Drug Discov. Dev"},{"key":"10.1016\/j.abb.2021.108788_bib49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrn731","article-title":"Emerging structure of the nicotinic acetylcholine receptors","volume":"3","author":"Karlin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"44","key":"10.1016\/j.abb.2021.108788_bib50","doi-asserted-by":"crossref","first-page":"27575","DOI":"10.1074\/jbc.271.44.27575","article-title":"Assembly of the nicotinic acetylcholine receptor","volume":"271","author":"Wang","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.abb.2021.108788_bib51","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/294462a0","article-title":"Multiple conductance states of single acetylcholine receptor channels in embryonic muscle cells","volume":"294","author":"Hamill","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.abb.2021.108788_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.bb.08.060179.001443","article-title":"Endogenous chemical receptors: some physical aspects","volume":"8","author":"Barrantes","year":"1979","journal-title":"Annu. Rev. Biophys. Bioeng."},{"issue":"11","key":"10.1016\/j.abb.2021.108788_bib53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/35097557","article-title":"Induction, assembly, maturation and maintenance of a postsynaptic apparatus","volume":"2","author":"Sanes","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.abb.2021.108788_bib54","first-page":"197","article-title":"Mechanisms of acetylcholine receptor loss from the neuromuscular junction","volume":"90","author":"Engel","year":"1982","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.abb.2021.108788_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.1976.tb47683.x","article-title":"Characteristics and mechanism of neuromuscular block in myasthenia gravis","volume":"274","author":"Grob","year":"1976","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4088","key":"10.1016\/j.abb.2021.108788_bib56","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"issue":"4212","key":"10.1016\/j.abb.2021.108788_bib57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.abb.2021.108788_bib58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10409239409086798","article-title":"The nicotinic acetylcholine receptor: structure and autoimmune pathology","volume":"29","author":"Conti-Tronconi","year":"1994","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.abb.2021.108788_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1196\/annals.1405.007","article-title":"Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains","volume":"1132","author":"Lindstrom","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.abb.2021.108788_bib60","series-title":"Cholesterol Effects on Nicotinic Acetylcholine Receptor: Cellular Aspects, Sub-cellular Biochemistry","first-page":"467","author":"Barrantes","year":"2010"},{"key":"10.1016\/j.abb.2021.108788_bib61","series-title":"Cholesterol Regulation of Ion Channels and Receptors","first-page":"183","article-title":"Regulation of the nicotinic acetylcholine receptor by cholesterol as a boundary lipid","author":"Barrantes","year":"2012"},{"issue":"20","key":"10.1016\/j.abb.2021.108788_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204838","article-title":"Lovastatin differentially regulates \u03b17 and \u03b14 neuronal nicotinic acetylcholine receptor levels in rat hippocampal neurons","volume":"25","author":"Borroni","year":"2020","journal-title":"Molecules"},{"issue":"Suppl 1","key":"10.1016\/j.abb.2021.108788_bib63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1471-4159.2007.04719.x","article-title":"Cholesterol effects on nicotinic acetylcholine receptor","volume":"103","author":"Barrantes","year":"2007","journal-title":"J.\u00a0Neurochem."},{"issue":"30","key":"10.1016\/j.abb.2021.108788_bib64","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1021\/bi034485q","article-title":"Lipid-protein interactions and effect of local anesthetics in acetylcholine receptor-rich membranes from Torpedo marmorata electric organ","volume":"42","author":"Mantipragada","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2021.108788_bib65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/srep00069","article-title":"Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor","volume":"1","author":"Baier","year":"2011","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.abb.2021.108788_bib66","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1210\/me.2004-0308","article-title":"Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor","volume":"19","author":"Jamin","year":"2005","journal-title":"Mol. Endocrinol."},{"issue":"12","key":"10.1016\/j.abb.2021.108788_bib67","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1210\/endo.139.12.6390","article-title":"Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition\/interaction amino acid sequence and consensus pattern","volume":"139","author":"Li","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.abb.2021.108788_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fphys.2013.00031","article-title":"How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains","volume":"4","author":"Fantini","year":"2013","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.abb.2021.108788_bib69","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.kijoms.2015.11.006","article-title":"A\u00a0novel fuzzy C-means approach for uncovering cholesterol consensus motif from human G-protein coupled receptors (GPCR)","volume":"1","author":"Tripathy","year":"2015","journal-title":"Karbala Int. J. Mod. Sci."},{"key":"10.1016\/j.abb.2021.108788_bib70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-030-14265-0_1","article-title":"Cholesterol-recognition motifs in membrane proteins","volume":"1135","author":"Fantini","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.abb.2021.108788_bib71","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.bbamem.2014.07.011","article-title":"The pore-lining regions in cytochrome c oxidases: a computational analysis of caveolin, cholesterol and transmembrane helix contributions to proton movement","volume":"1838","author":"Morrill","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.abb.2021.108788_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2016.06.143","article-title":"The role of receptor topology in the vitamin D3 uptake and Ca2+ response systems","author":"Morrill","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"360","key":"10.1016\/j.abb.2021.108788_bib73","article-title":"Molecular properties of globin channels and pores: role of cholesterol in ligand binding and movement","volume":"7","author":"Morrill","year":"2016","journal-title":"Front. Physiol."},{"issue":"20","key":"10.1016\/j.abb.2021.108788_bib74","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation","volume":"298","author":"Drachman","year":"1978","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib75","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00005072-198211000-00001","article-title":"Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis","volume":"41","author":"Fumagalli","year":"1982","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"issue":"19","key":"10.1016\/j.abb.2021.108788_bib76","doi-asserted-by":"crossref","first-page":"17122","DOI":"10.1074\/jbc.M110.211870","article-title":"Cholesterol modulates the rate and mechanism of acetylcholine receptor internalization","volume":"286","author":"Borroni","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib77","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2004.06.007","article-title":"Metabolic cholesterol depletion hinders cell-surface trafficking of the nicotinic acetylcholine receptor","volume":"128","author":"Pediconi","year":"2004","journal-title":"Neuroscience"},{"issue":"17","key":"10.1016\/j.abb.2021.108788_bib78","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1038\/sj.emboj.7601288","article-title":"Cholesterol and lipid microdomains stabilize the postsynapse at the neuromuscular junction","volume":"25","author":"Willmann","year":"2006","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib79","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1083\/jcb.200202110","article-title":"Laminin-1 redistributes postsynaptic proteins and requires rapsyn, tyrosine phosphorylation, and Src and Fyn to stably cluster acetylcholine receptors","volume":"157","author":"Marangi","year":"2002","journal-title":"J.\u00a0Cell Biol."},{"issue":"9","key":"10.1016\/j.abb.2021.108788_bib80","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1194\/jlr.M005132","article-title":"Partition profile of the nicotinic acetylcholine receptor in lipid domains upon reconstitution","volume":"51","author":"Bermudez","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.abb.2021.108788_bib81","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.abb.2015.12.003","article-title":"Transbilayer asymmetry and sphingomyelin composition modulate the preferential membrane partitioning of the nicotinic acetylcholine receptor in Lo domains","volume":"591","author":"Perillo","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"16","key":"10.1016\/j.abb.2021.108788_bib82","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1016\/S0021-9258(19)68891-5","article-title":"Mapping of surface structures of electrophorus acetylcholine receptor using monoclonal antibodies","volume":"256","author":"Tzartos","year":"1981","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.abb.2021.108788_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1981.tb33721.x","article-title":"Structure and function of acetylcholine receptors studied using monoclonal antibodies","volume":"377","author":"Lindstrom","year":"1982","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib84","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jnc.14905","article-title":"Antibody-induced crosslinking and cholesterol-sensitive, anomalous diffusion of nicotinic acetylcholine receptors","volume":"152","author":"Mosqueira","year":"2020","journal-title":"J.\u00a0Neurochem."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib85","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1038\/s41598-018-30384-y","article-title":"Cholesterol modulates acetylcholine receptor diffusion by tuning confinement sojourns and nanocluster stability","volume":"8","author":"Mosqueira","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.abb.2021.108788_bib86","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/0028-3886.65533","article-title":"Apolipoprotein-E genotypes and myasthenia gravis","volume":"58","author":"Suhail","year":"2010","journal-title":"Neurol. India"},{"key":"10.1016\/j.abb.2021.108788_bib87","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1749-6632.1998.tb10991.x","article-title":"Apolipoprotein E in myasthenia gravis","volume":"841","author":"Sostarko","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.abb.2021.108788_bib88","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archneur.57.11.1561","article-title":"Apolipoprotein E and neuromuscular disease: a critical review of the literature","volume":"57","author":"Bedlack","year":"2000","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.abb.2021.108788_bib89","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.abb.2021.108788_bib90","series-title":"Type III Hyperlipoproteinemia (Dysbetalipoproteinemia), the Metabolic and Molecular Bases of Inherited Disease","first-page":"2835","author":"Mahley","year":"2001"},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib91","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"issue":"3","key":"10.1016\/j.abb.2021.108788_bib92","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1083\/jcb.107.3.1207","article-title":"Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state","volume":"107","author":"Majack","year":"1988","journal-title":"J.\u00a0Cell Biol."},{"issue":"4","key":"10.1016\/j.abb.2021.108788_bib93","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1172\/JCI111325","article-title":"Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism","volume":"73","author":"Cuthbert","year":"1984","journal-title":"J.\u00a0Clin. Invest."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib94","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/s41467-018-05322-1","article-title":"Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation","volume":"9","author":"Bonacina","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib95","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1038\/s41598-020-68185-x","article-title":"AChR antibodies show a complex interaction with human skeletal muscle cells in a transcriptomic study","volume":"10","author":"Hong","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.abb.2021.108788_bib96","first-page":"581","article-title":"[Glucose and lipid metabolic disorders in myasthenia gravis patients and its mechanisms]","volume":"98","author":"Li","year":"2018","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"8934","key":"10.1016\/j.abb.2021.108788_bib97","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study","volume":"344","year":"1994","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.abb.2021.108788_bib98","doi-asserted-by":"crossref","first-page":"990","DOI":"10.7326\/0003-4819-125-12-199612150-00011","article-title":"Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment","volume":"125","author":"Schectman","year":"1996","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.abb.2021.108788_bib99","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","volume":"54","author":"Hiro","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"5519","key":"10.1016\/j.abb.2021.108788_bib100","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"issue":"9364","key":"10.1016\/j.abb.2021.108788_bib101","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.abb.2021.108788_bib102","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jamacardio.2019.2306","article-title":"Effect of simvastatin-ezetimibe compared with simvastatin monotherapy after acute coronary syndrome among patients 75 Years or older: a secondary analysis of a randomized clinical trial","volume":"4","author":"Bach","year":"2019","journal-title":"JAMA Cardiol."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fund. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.abb.2021.108788_bib104","doi-asserted-by":"crossref","first-page":"183340","DOI":"10.1016\/j.bbamem.2020.183340","article-title":"Pleiotropic effects of statins on brain cells","volume":"1862","author":"Sodero","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","article-title":"The lipid and non-lipid effects of statins","volume":"99","author":"Wierzbicki","year":"2003","journal-title":"Pharmacol. Therapeut."},{"issue":"12","key":"10.1016\/j.abb.2021.108788_bib107","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib108","first-page":"1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species, Hypertension (Dallas, Tex.: 1979)","volume":"37","author":"Wassmann","year":"2001"},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib109","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cardiores.2006.04.005","article-title":"Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy","volume":"71","author":"Custodis","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0735-1097(97)00129-0","article-title":"Platelet-dependent thrombin generation in patients with hyperlipidemia","volume":"30","author":"Aoki","year":"1997","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.abb.2021.108788_bib111","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.ATV.0000022694.16328.CC","article-title":"Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients","volume":"22","author":"Rezaie-Majd","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"13","key":"10.1016\/j.abb.2021.108788_bib112","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.CIR.0000091404.09558.AF","article-title":"High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study","volume":"108","author":"Kinlay","year":"2003","journal-title":"Circulation"},{"issue":"23 Suppl 1","key":"10.1016\/j.abb.2021.108788_bib113","first-page":"Iii39","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.abb.2021.108788_bib114","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2174\/1381612820666141013134447","article-title":"Adverse effects of statins - myths and reality","volume":"21","author":"\u0160imi\u0107","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.steroids.2004.03.012","article-title":"High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in Guinea pigs","volume":"69","author":"L\u00fctjohann","year":"2004","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib116","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jacl.2011.06.007","article-title":"Statins and their influence on brain cholesterol","volume":"5","author":"Cibi\u010dkov\u00e1","year":"2011","journal-title":"J.\u00a0Clin. Lipidol."},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib117","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI0216390","article-title":"Cholesterol, lipid rafts, and disease","volume":"110","author":"Simons","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib118","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00001756-200104170-00003","article-title":"Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice","volume":"12","author":"Eckert","year":"2001","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1194\/jlr.M081240","article-title":"Cholesterol intake and statin use regulate neuronal G protein-gated inwardly rectifying potassium channels","volume":"60","author":"Bukiya","year":"2019","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.abb.2021.108788_bib120","article-title":"Chronic cholesterol depletion using statin impairs the function and dynamics of human Serotonin1A receptors","author":"Shrivastava","year":"2010","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.abb.2021.108788_bib121","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/npp.2010.20","article-title":"Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants","volume":"35","author":"Nothdurfter","year":"2010","journal-title":"Neuropsychopharmacology: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib122","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002018-200022060-00003","article-title":"HMG-CoA reductase inhibitors and myotoxicity","volume":"22","author":"Ucar","year":"2000","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib123","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11883-003-0079-x","article-title":"Statins and myotoxicity","volume":"5","author":"Farmer","year":"2003","journal-title":"Curr. Atherosclerosis Rep."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib124","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbspin.2019.01.018","article-title":"Statins, myalgia, and rhabdomyolysis","volume":"87","author":"Tournadre","year":"2020","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib125","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjmed.2003.10.033","article-title":"Current overview of statin-induced myopathy","volume":"116","author":"Rosenson","year":"2004","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib126","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2003.12.037","article-title":"Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors","volume":"147","author":"Jamal","year":"2004","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib127","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2004.08.076","article-title":"Reporting rate of rhabdomyolysis with fenofibrate\u00a0+ statin versus gemfibrozil\u00a0+ any statin","volume":"95","author":"Jones","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"14","key":"10.1016\/j.abb.2021.108788_bib128","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinte.166.14.1519","article-title":"Presymptomatic neuromuscular disorders disclosed following statin treatment","volume":"166","author":"Tsivgoulis","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.abb.2021.108788_bib131","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.febslet.2009.11.036","article-title":"Neuronal nicotinic acetylcholine receptor\u2013cholesterol crosstalk in Alzheimer's disease","volume":"584","author":"Barrantes","year":"2010","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.abb.2021.108788_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09687860600903387","article-title":"Cholesterol depletion activates rapid internalization of submicron-sized acetylcholine receptor domains at the cell membrane","volume":"24","author":"Borroni","year":"2007","journal-title":"Mol. Membr. Biol."},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051046","article-title":"Cholesterol and the safety factor for neuromuscular transmission","volume":"20","author":"Krivoi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.abb.2021.108788_bib134","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11910-020-01064-0","article-title":"Neuromuscular complications of statin therapy","volume":"20","author":"Crisan","year":"2020","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"3","key":"10.1016\/j.abb.2021.108788_bib135","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/mus.21074","article-title":"Statins may aggravate myasthenia gravis","volume":"38","author":"Oh","year":"2008","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib136","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jocn.2013.11.009","article-title":"Statins can induce myasthenia gravis","volume":"21","author":"Gale","year":"2014","journal-title":"J.\u00a0Clin. Neurosci.: Off. J. Neurosurg. Soc. Australasia"},{"issue":"11","key":"10.1016\/j.abb.2021.108788_bib137","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1212\/01.WNL.0000145708.03876.C3","article-title":"Statin-associated exacerbation of myasthenia gravis","volume":"63","author":"Cartwright","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.abb.2021.108788_bib138","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1752-1947-4-61","article-title":"Statin-associated weakness in myasthenia gravis: a case report","volume":"4","author":"Keogh","year":"2010","journal-title":"J.\u00a0Med. Case Rep."},{"issue":"9334","key":"10.1016\/j.abb.2021.108788_bib139","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(02)09846-X","article-title":"Statins, fibrates, and ocular myasthenia","volume":"360","author":"Parmar","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.md.0000209337.59874.aa","article-title":"Statin-associated myasthenia gravis: report of 4 cases and review of the literature","volume":"85","author":"Purvin","year":"2006","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.abb.2021.108788_bib141","first-page":"427","article-title":"Reversible atorvastatin-associated external ophthalmoplegia, anti-acetylcholine receptor antibodies, and ataxia","volume":"118","author":"Negevesky","year":"2000","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.abb.2021.108788_bib142","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ejcn.2012.191","article-title":"\u03b2-glucans reduce LDL cholesterol in patients with myasthenia gravis","volume":"67","author":"Hagg\u00e5rd","year":"2013","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.abb.2021.108788_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.02.029","article-title":"Myotoxicity of statins: mechanism of action","volume":"175","author":"du Souich","year":"2017","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.abb.2021.108788_bib144","first-page":"218","article-title":"Biochemical and clinical consequences of inhibiting coenzyme Q biosynthesis by lipid-lowering HMG-Co A reductase inhibitors (statins): a critical overview","volume":"15","author":"Bliznakov","year":"1998","journal-title":"Adv. Ther."},{"issue":"5","key":"10.1016\/j.abb.2021.108788_bib145","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.RES.83.5.490","article-title":"3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture","volume":"83","author":"Guijarro","year":"1998","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.abb.2021.108788_bib146","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/mus.880170808","article-title":"Electrical myotonia of rabbit skeletal muscles by HMG-CoA reductase inhibitors","volume":"17","author":"Sonoda","year":"1994","journal-title":"Muscle Nerve"},{"issue":"6911","key":"10.1016\/j.abb.2021.108788_bib147","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.abb.2021.108788_bib148","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1196\/annals.1254.032","article-title":"T\u00a0cells and cytokines in the pathogenesis of acquired myasthenia gravis","volume":"998","author":"Milani","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.abb.2021.108788_bib149","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0002-9343(01)01102-0","article-title":"Atorvastatin-induced reversible positive antinuclear antibodies","volume":"112","author":"Jim\u00e9nez-Alonso","year":"2002","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00005792-199811000-00002","article-title":"Systemic immune reactions to HMG-CoA reductase inhibitors. Report of 4 cases and review of the literature","volume":"77","author":"Rudski","year":"1998","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.abb.2021.108788_bib151","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/mus.20127","article-title":"Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake","volume":"30","author":"Vasconcelos","year":"2004","journal-title":"Muscle Nerve"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986121000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986121000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:03:21Z","timestamp":1762088601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986121000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":151,"alternative-id":["S0003986121000382"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2021.108788","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2021.108788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108788"}}